2-[(4-hydroxycyclohexyl)amino]-4-(4-naphthalen-2-yl-3-propan-2-ylpyrazolo[3,4-b]pyridin-1-yl)benzamide
C32H33N5O2 — CID 155527383
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[(4-hydroxycyclohexyl)amino]-4-(4-naphthalen-2-yl-3-propan-2-ylpyrazolo[3,4-b]pyridin-1-yl)benzamide
2-[(4-hydroxycyclohexyl)amino]-4-(4-naphthalen-2-yl-3-propan-2-ylpyrazolo[3,4-b]pyridin-1-yl)benzamide (PubChem CID 155527383) has the molecular formula C32H33N5O2 and a molecular weight of 519.65 g/mol. Its IUPAC name is 2-[(4-hydroxycyclohexyl)amino]-4-(4-naphthalen-2-yl-3-propan-2-ylpyrazolo[3,4-b]pyridin-1-yl)benzamide.
Molecular Properties
| Compound Name | 2-[(4-hydroxycyclohexyl)amino]-4-(4-naphthalen-2-yl-3-propan-2-ylpyrazolo[3,4-b]pyridin-1-yl)benzamide |
|---|---|
| PubChem CID | 155527383 |
| Molecular Formula | C32H33N5O2 |
| Molecular Weight | 519.65 g/mol |
| Exact Mass | 519.26 |
| IUPAC Name | 2-[(4-hydroxycyclohexyl)amino]-4-(4-naphthalen-2-yl-3-propan-2-ylpyrazolo[3,4-b]pyridin-1-yl)benzamide |
| SMILES | CC(C)c1nn(-c2ccc(C(N)=O)c(NC3CCC(O)CC3)c2)c2nccc(-c3ccc4ccccc4c3)c12 |
| InChI | InChI=1S/C32H33N5O2/c1-19(2)30-29-26(22-8-7-20-5-3-4-6-21(20)17-22)15-16-34-32(29)37(36-30)24-11-14-27(31(33)39)28(18-24)35-23-9-12-25(38)13-10-23/h3-8,11,14-19,23,25,35,38H,9-10,12-13H2,1-2H3,(H2,33,39) |
| InChIKey | CDCXOJRVVSFJFS-UHFFFAOYSA-N |
| XLogP | 6.18 |
| TPSA | 106.06 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 39 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 519.65 |
| LogP ≤ 5 | 6.18 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155527383 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.